Blood transfusion is the process of transferring blood or blood products into one's circulation intravenously. Transfusions are used for various medical conditions to replace lost components of the blood. Early transfusions used whole blood, but modern medical practice commonly uses only components of the blood, such as PRBCs, Plasma, and Platelets.
Immunohematology (IH) is a branch of hematology which studies antigen-antibody reactions and analogous phenomena as they relate to the pathogenesis and clinical manifestations of blood disorders. IH is more commonly known in blood banking. Tests include blood typing, cross-matching and antibody screening.
Nucleic Acid Test (NAT) is a highly sensitive method for screening blood donors. Most traditional screening tests require the presence of antibodies to trigger a positive test reaction.
The NAT system differs from other tests in that it detects genetic materials rather than antigens or antibodies. Detection of genetic materials allows an early diagnosis of a disease because the detection of antigens requires time for antigens to appear in the bloodstream. Since the amount of a certain genetic material is usually very small, NAT includes an amplification step of the genetic material.
Genotyping Tests for Detection of Red Blood Cell and Human Platelet Antigens: Blood group compatibility between donor and patient is the key to guaranteeing this safety. For more than twenty years, Grifols has researched and developed blood typing systems that have enabled millions of safe transfusions to be performed all over the world.
Grifols Blood genotyping BLOODchip® is a fast and effective solution for typing the most clinically relevant blood group antigens. The test provides detailed information to ensure maximum compatibility between the patient and the donor so that you can offer the safest transfusion therapy possible.
Apheresis is a medical procedure that involves removing whole blood from a donor or patient and separating the blood into individual components so that one particular component can be removed. The remaining blood components then are re-introduced back into the bloodstream of the patient or donor.
Our Blood Bank Unit, in partnership with major international companies, provides highly specialized products and services required by blood transfusion centers to enhance patient safety. The unit represents one of the most reputable companies in the world in the field of blood banks and blood transfusions. This Unit offers several complete solutions with advance technologies for blood banks.
Our products are widely used in several institutions, blood banks, and transfusion centers around the Kingdom supported by a team of highly skilled and qualified professionals.
We have succeeded in establishing good references around the kingdom. Our products and services are used widely by several blood banks in Government and Private sectors.
Our main Partners:
Grifols is a global healthcare company with more than 75 years of history improving the health and well-being of people around the world. We produce essential plasma medicines for patients and provide.
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used.